Are Mast Cells Involved in Autoinflammatory Diseases

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Autoinflammatory diseases (AID) are caused by innate immunity dysregulation. AID pathophysiology is only partly understood, especially in the case of unclassified AID. Mast cells (MC) are innate immune cells associated with a spectrum of disease between systemic mastocytosis and mast cell activation syndrome. The implication of MC has been shown in cryopyrin associated periodic syndrome (CAPS).Our aim is to evaluate the involvement of MC in AID by assessing clinical and biological signs of MC activation and studying cutaneous and digestive biopsies.

Eligibility criteria

Qualifiers

Patients >18 years old with Auto-inflammatory diseases already followed up at the CeRéMAIA (french national reference center for autoinflamamtory diseases and AA amyloidosis) of Tenon hospital and included in the JIRcohorte

Healthy adult controls, age- and sex-matched with MAI patients, and controls with mastocytosis, an immuno-inflammatory disease.

Subject affiliated to or entitled to a social security scheme

Collection of the patient's or healthy control's non-opposition

Disqualifiers

Subjects unable to answer questions or express themselves

Subjects who do not speak French

Subject deprived of liberty or under legal protection.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

590 Participants
are grouped into 6 trial groups

6

Trial groups

See each trial group below.

Sponsors and collaborators